Your browser doesn't support javascript.
loading
Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.
Lakhashe, Samir K; Byrareddy, Siddappa N; Zhou, Mingkui; Bachler, Barbara C; Hemashettar, Girish; Hu, Shiu-Lok; Villinger, Francois; Else, James G; Stock, Shannon; Lee, Sandra J; Vargas-Inchaustegui, Diego A; Cofano, Egidio Brocca; Robert-Guroff, Marjorie; Johnson, Welkin E; Polonis, Victoria R; Forthal, Donald N; Loret, Erwann P; Rasmussen, Robert A; Ruprecht, Ruth M.
Afiliação
  • Lakhashe SK; Texas Biomedical Research Institute, San Antonio, TX, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Byrareddy SN; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Zhou M; Texas Biomedical Research Institute, San Antonio, TX, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Bachler BC; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hemashettar G; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hu SL; University of Washington, Seattle, WA, USA.
  • Villinger F; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA; Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
  • Else JG; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA; Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
  • Stock S; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lee SJ; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Vargas-Inchaustegui DA; Vaccine Branch, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
  • Cofano EB; Vaccine Branch, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
  • Robert-Guroff M; Vaccine Branch, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
  • Johnson WE; Biology Department, Boston College, MA, USA.
  • Polonis VR; The Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
  • Forthal DN; Division of Infectious Diseases, Department of Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA.
  • Loret EP; ETRAV Laboratory, Faculty of Pharmacy, Aix Marseille University/CNRS, 27 BD Jean Moulin, 13385 Marseille Cedex 5, France.
  • Rasmussen RA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Ruprecht RM; Texas Biomedical Research Institute, San Antonio, TX, USA; Southwest National Primate Research Center, San Antonio, TX, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: rruprecht@txbiomed.org.
Vaccine ; 32(48): 6527-36, 2014 Nov 12.
Article em En | MEDLINE | ID: mdl-25245933
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinação / Vacinas contra a AIDS / Imunidade nas Mucosas Limite: Animals Idioma: En Revista: Vaccine Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinação / Vacinas contra a AIDS / Imunidade nas Mucosas Limite: Animals Idioma: En Revista: Vaccine Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos